Immunome (IMNM) Stock: Buy, Sell, or Hold?
IMNM - Immunome, Inc.
$18.21
-0.08 (-0.44%)
âŧ
5d:
+1.22%
30d:
-12.83%
90d:
-20.86%
WAIT
LOW Confidence
Analysis Updated: Oct 30, 2026 12:00 AM ET
Earnings: Nov 05, 2026
3d
Get Alerted When IMNM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: IMNM is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: IMNM is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: IMNM is currently trading at $18.21, which is considered slightly low relative to its 30-day fair value range of $17.46 to $21.25.
Technical Outlook: Technically, IMNM is showing sideways momentum. Immediate support is located at $16.44, while resistance sits at $19.30.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Implied Volatility is high (100th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $35.33 (+94.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IMNM is showing sideways momentum. Immediate support is located at $16.44, while resistance sits at $19.30.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Implied Volatility is high (100th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $35.33 (+94.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$17.46 -
$21.25
Company Quality Score
52/100
(HOLD)
Options IV Signal
100th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
65.4%
Protect Your Profits
Holding IMNM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Options expensive (IV 100th percentile)
- NEUTRAL: Mixed technical signals (41/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 94.0% below Wall St target ($35.33)
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$17.46 -
$21.25
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
Âą$4.72
(25.9%)
Support & Resistance Levels
Support Level
$16.44
Resistance Level
$19.30
Current Trend
Sideways
Technical data as of
Oct 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.41
Wall Street Target
$35.33
(+94.0%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: November 01, 2026 12:10 AM ET
Data refreshes hourly during market hours. Next update: 1:10 AM
Data refreshes hourly during market hours. Next update: 1:10 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMNM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
23 analysts |
$109 | 65 BUY |
|
VRTX
Vertex Pharmaceuticals IâĻ |
STRONG BUY
32 analysts |
$571 | 31 SELL |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$196 | 43 HOLD |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$685 | 62 BUY |
|
CGON
CG Oncology, Inc. CommonâĻ |
STRONG BUY
15 analysts |
$91 | 65 BUY |
Advanced IMNM Option Strategies
Professional options setups generated by AI based on today's IMNM price and gamma walls.
